ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Short Interest Update

ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) was the recipient of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 500 shares, an increase of 400.0% from the March 31st total of 100 shares. Based on an average trading volume of 40,500 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the shares of the stock are sold short.

ARYA Sciences Acquisition Corp IV Price Performance

NASDAQ:ARYD traded down $0.02 during mid-day trading on Thursday, reaching $11.33. 15,615 shares of the stock were exchanged, compared to its average volume of 46,820. The business has a fifty day moving average price of $11.26 and a 200 day moving average price of $11.04. ARYA Sciences Acquisition Corp IV has a 1-year low of $10.41 and a 1-year high of $11.39.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Mizuho Securities USA LLC grew its holdings in ARYA Sciences Acquisition Corp IV by 6.4% during the third quarter. Mizuho Securities USA LLC now owns 104,345 shares of the company’s stock worth $1,116,000 after acquiring an additional 6,278 shares during the period. Cowen AND Company LLC boosted its holdings in shares of ARYA Sciences Acquisition Corp IV by 85.1% in the third quarter. Cowen AND Company LLC now owns 192,561 shares of the company’s stock worth $2,084,000 after buying an additional 88,505 shares during the period. Virtu Financial LLC purchased a new position in shares of ARYA Sciences Acquisition Corp IV in the fourth quarter worth approximately $204,000. Berkley W R Corp raised its holdings in shares of ARYA Sciences Acquisition Corp IV by 24.3% during the fourth quarter. Berkley W R Corp now owns 188,862 shares of the company’s stock valued at $2,055,000 after acquiring an additional 36,888 shares during the period. Finally, Hsbc Holdings PLC purchased a new stake in shares of ARYA Sciences Acquisition Corp IV in the 4th quarter valued at approximately $1,630,000. 48.08% of the stock is owned by institutional investors and hedge funds.

ARYA Sciences Acquisition Corp IV Company Profile

Arya Sciences Acquisition Corp IV does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on acquiring North American or European companies in the life sciences and medical technology sectors.